Events
-
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Justin Greiwe, MDLearn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
Clinical Case Discussion: An Adult Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
Virtual (Zoom)
by Andrew Baker, PA-CJoin us for a program discussing a real-world case of an adult patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation.
-
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
Virtual (Zoom)
by Justin Love, PA-CLearn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Gina Mangin, PA-CThis program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. Register
-
Exploring the Pathophysiology of Type 2 Inflammation in Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
Virtual (Zoom)
by Cynthia Trickett, PA-CLearn more about the evolving understanding of the pathophysiology of chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate CSU patients 12+ years of age.
-
DUPIXENT@ (dupilumab) Pediatric Caregiver Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Lisa Swanson, MDJoin us for a virtual discussion with an expert speaker and a caregiver of a pediatric patient with atopic dermatitis (AD) to learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Ty Hanson, DOLearn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
Virtual (Zoom)
by Matthew Lewis, MDLearn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations and a treatment option for appropriate BP patients
-
Clinical Case Discussion: An Adult Patient with Prurigo Nodularis and a Treatment Option for Appropriate Patients 18+ Years of Age
Virtual (Zoom)
by Michael Payette, MDJoin us for a program discussing a real-world case of an adult patient with prurigo nodularis (PN) and a treatment option that may help appropriate patients.
-
Clinical Case Discussion: A Pediatric Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
Virtual (Zoom)
by Dareen Siri, MDJoin us for a program discussing a real-world case of a pediatric patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation.
-
DUPIXENT® (dupilumab) Pediatric Caregiver Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Dareen Siri, MDJoin us for a virtual discussion with an expert speaker and a caregiver of a pediatric patient with atopic dermatitis (AD) to learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients.
Virtual (Zoom)
by Linda Stein Gold, MDLearn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Eileen Cheever, PA-CThis program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. Register
-
DUPIXENT@ (dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Zakiya Rice, MDJoin us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
Clinical Case Discussion: An Adult Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
Virtual (Zoom)
by Marshall Shuler, MDJoin us for a program discussing a real-world case of an adult patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation
-
Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
Virtual (Zoom)
by Timothy Patton, DOLearn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations and a treatment option for appropriate BP patients <!---->
-
DUPIXENT®(dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Roopen Patel, MDJoin us for a virtual discussion with an expert speaker and an adult patient with atopic dermatitis (AD) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Douglas DiRuggiero, PA-CThis program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. Register
-
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Ben Ehst, MDLearn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Marc Serota, MDLearn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Karan Lal, DOThis program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. Register
-
DUPIXENT@ (dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Omar Noor, MDJoin us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
Clinical Case Discussion: A Pediatric Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
Virtual (Zoom)
by Autumn Burnette, MDJoin us for a program discussing a real-world case of a pediatric patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation
-
Clinical Case Discussion: An Adolescent Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
Virtual (Zoom)
by Amy Spizuoco, DOJoin us for a program discussing a real-world case of an adolescent patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation
-
Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
Virtual (Zoom)
by Daniel Butler, MDLearn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations and a treatment option for appropriate BP patients
-
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
Virtual (Zoom)
by Leigh Ann Pansch, NPLearn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years of age
-
DUPIXENT@ (dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Lakshi Aldredge, NPJoin us for a virtual discussion with an expert speaker and an adult patient with atopic dermatitis (AD) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
DUPIXENT@(dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Sandri Johnson, NPJoin us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
-
Clinical Case Discussion: A Pediatric Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
Virtual (Zoom)
by Brittany Craiglow, MDJoin us for a program discussing a real-world case of a pediatric patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation.
-
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
Virtual (Zoom)
by Raffi Tachdjian, MDLearn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation